Advertisement

Oncology / Hematology General

22-Gene Genomic Classifier for Recurrent Prostate Cancer

Decipher Biosciences Inc. (Decipher) is a genomic classifier (GC) that could help estimate the risk of distant metastasis (DM) after radical prostatectomy in patients with prostate cancer. The effectiveness of the classifier is...

Tislelizumab Plus Chemotherapy for Small-Cell Lung Cancer

Recent studies have shown that adding tislelizumab, a humanized monoclonal antibody directed against PD-1, to standard chemotherapy can improve outcomes in patients with advanced squamous non-small-cell lung cancer (NSCLC). This...

Combination Therapy for Newly Diagnosed Multiple Myeloma

Combination therapy of weekly lzomib, lenalidomide, dexamethasone is used for patients with newly diagnosed multiple myeloma. Recent studies show that adding daratumumab to this weekly dosing can increase the safety and efficacy...

Body Radiotherapy for the Treatment of Multiple Metastases

Stereotactic body radiotherapy (SBRT) has shown positive outcomes in improving survival among patients with oligometastases. However, not many studies have analyzed its safety and efficacy in treating patients with multiple...

Optimal Chemotherapy Regimen for Ovarian Cancer

Among vulnerable older patients with ovarian cancer, single-agent carboplatin is proposed instead of conventional carboplatin-paclitaxel doublet therapy. The effects of this approach on patients have not been well-studies. This...

Loading